Skip to content

Nkarta, Inc.

NKTX· NasdaqCore metricsCIK 1787400

Pharmaceutical preparations552 peers

Last sale
Nov 12, 2026 · -14.53%
Market cap
$90.71M
71.7M shares
Filings
440
$0.00
FY 2025
-$33.33M
Q3 2026N/M FY25 yoy
-$35.78M
Q3 2026N/M FY25 yoy
-$80.10M
Q3 2026derivedN/M FY25 yoy
-$0.45
Q3 2026N/M FY25 yoy
$48.35M
Q3 2026+42.2% FY25 yoy
$90.71M
—
—
0.4×
-99.12%
—

FY2025 figures · derived

Price

$1.2737.22%$0.75past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$0.00FY 2025
$115.00K0FY 2019FY 2024FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31$0reported
FY 20242024-12-31$0reported
FY 20192019-12-31$115,000reported

Pharmaceutical preparations

Nkarta, Inc. is the 296th largest of the 553 covered companies the SEC files under this code, by market cap. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Nkarta, Inc. · CIK 1787400 · Engraved from SEC EDGAR